Full-Time

Quality Investigations Specialist 2

Updated on 9/10/2026

Curia

Curia

1,001-5,000 employees

End-to-end drug development and manufacturing

No salary listed

Albuquerque, NM, USA

In Person

Bachelor's, Associate's

Category
Biology & Biotech (1)
Required Skills
Quality Assurance (QA)

Get referred to Curia

See people who can refer or advise you

Requirements
  • An Associate’s Degree in Science, Chemistry, Biology, or a related field of study.
  • A minimum of three years of quality assurance and/or regulatory experience in the pharmaceutical industry, with demonstrated understanding of laboratory, manufacturing, packaging, regulatory, compliance, and quality assurance requirements for biological and drug product manufacturing.
  • Ability to provide guidance and mentorship to team members.
  • Ability to foster a collaborative and positive work environment.
  • Ability to champion change.
  • Ability to promote a safe and healthy work environment by actively identifying and addressing potential hazards, following established safety protocols, participating in safety training programs, and fostering a culture of awareness and responsibility among team members.
  • Strong attention to detail.
  • Ability to pass a background check and drug screen.
  • Ability to pass an occupational health screening if required.
Responsibilities
  • Provide Quality Assurance oversight, leadership, and subject matter expertise for current Good Manufacturing Practice investigations.
  • Work with Quality and Operations to maintain facilities and processes in a constant state of readiness for regulatory and customer inspections.
  • Work with Quality and Operations to support on-time and right-first-time execution of production activities.
  • Support product complaints, deviations, and failure investigations.
  • Serve as a subject matter expert for related analytical and technical Quality Assurance.
  • Review and close investigations and customer concerns.
  • Perform root cause analysis and implement corrective action for process-related concerns.
  • Recommend and initiate changes to applicable standard operating procedures.
  • Support the Compliance department during Food and Drug Administration and other agency inspections, as well as customer and internal audits.
  • Maintain working knowledge of government and industry Quality Assurance codes and standards.
  • Participate in site or global projects and improvement efforts as needed.
  • Read and interpret standard operating procedures to ensure compliance.
  • Maintain up-to-date training.
Desired Qualifications
  • A Bachelor’s Degree in Science, Chemistry, Biology, or a related field of study.

Curia is a contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to move medical breakthroughs from concept to market. It provides end-to-end services across the drug development lifecycle, including early research, method development and validation, preformulation, material science, solid-state chemistry, and package device testing. Revenue comes from service contracts for specialized capabilities and expertise, with clients ranging from small startups to large pharma. Curia also collaborates with industry leaders to advance continuous flow development and manufacturing programs. The company differentiates itself through flexible and scalable solutions, deep scientific expertise, and state-of-the-art technology that help clients accelerate development timelines while navigating discovery to commercialization. Its goal is to enable efficient, reliable progression of drug candidates from conception through to market approval.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$132M

Headquarters

Albany, New York

Founded

1991

Get referred to Curia

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Curia expanded Glasgow sterile drug product capacity in March 2026.
  • Curia completed a $4 million sterile API upgrade in Valladolid in October 2025.
  • Curia won a 2025 CDMO Leadership Award in Global Biologics.

What critics are saying

  • Curia is closing Burlington in 2026 and cutting 81 jobs.
  • Curia is working on an out-of-court restructuring with private credit lenders.
  • Asset sales like Pace’s New Jersey lab purchase signal continued portfolio shrinkage.

What makes Curia unique

  • Curia spans discovery through commercial manufacturing across small molecules and biologics.
  • Curia manufactures mRNA and self-replicating RNA, including Replicate Bioscience’s RBI-4000.
  • Curia runs 20+ global sites with sterile fill-finish and cell-line development.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Carlyle
Jan 30th, 2026
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR | Carlyle

ALBANY, N.Y. – Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced the completion of its previously announced acquisition by affiliates of The Carlyle Group (“Carlyle”) and affiliates of GTCR LLC (“GTCR”). President and Chief Executive Officer William S. Marth will continue to lead AMRI.

BERNAMA
May 10th, 2024
BIOLOGICS SYMPOSIUM: CURIA, CARTERRA PARTNER TO ADVANCE BIOTECH RESEARCH IN PACIFIC NORTHWEST

KUALA LUMPUR, May 10 (Bernama) - Curia, a contract research, development and manufacturing organisation (CDMO) has announced a partnership with Carterra Inc in hosting a high-throughput biologics symposium slated for May 31, in Seattle, Washington.

PharmiWeb
Mar 14th, 2024
Pace® Life Sciences Acquires New Jersey Laboratory From Curia

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

Pakistan Press International
Feb 23rd, 2024
Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) - Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.

Cameroon Online News
Feb 5th, 2024
Curia Receives 2024 CDMO Leadership Award

Curia was awarded based on the feedback of respondents in the Small Pharma category.